Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 161
- +7 vs. Q3 2023
- Portfolio value
- $6.54B
- +$330.6M (+5.3%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| IONSIonis Pharmaceuticals Inc | COM | 8,713,987 | $440.8M | 6.7% | −519,713−5.6% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 869,208 | $330.7M | 5.1% | −42,322−4.6% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 2,430,500 | $320.2M | 4.9% | −153,050−5.9% | Reduced | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 736,390 | $299.6M | 4.6% | −266,345−26.6% | Reduced | History |
| ISRGIntuitive Surgical Inc | COM NEW | 832,041 | $280.7M | 4.3% | +3,042+0.4% | Added | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 3,066,400 | $219.6M | 3.4% | −103,850−3.3% | Reduced | History |
| MRNAModerna, Inc. | Stock | 1,908,420 | $189.8M | 2.9% | +413,095+27.6% | Added | History |
| BSXBoston Scientific Corp | Stock | 3,170,603 | $183.3M | 2.8% | +524,308+19.8% | Added | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 885,318 | $169.5M | 2.6% | −9,027−1.0% | Reduced | History |
| ABTAbbott Laboratories | Stock | 1,535,656 | $169.0M | 2.6% | −25,312−1.6% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 5,091,000 | $146.0M | 2.2% | +369,500+7.8% | Added | History |
| SYKStryker Corp | Stock | 465,724 | $139.5M | 2.1% | −9,889−2.1% | Reduced | History |
| INCYIncyte Corp | COM | 2,156,719 | $135.4M | 2.1% | −334,731−13.4% | Reduced | History |
| AXNXAxonics, Inc. | COM | 1,833,165 | $114.1M | 1.7% | −419,686−18.6% | Reduced | History |
| DXCMDexcom Inc | COM | 914,593 | $113.5M | 1.7% | +228,860+33.4% | Added | History |
| ARVNArvinas, Inc. | COM | 2,507,731 | $103.2M | 1.6% | +382,531+18.0% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 2,416,296 | $95.8M | 1.5% | +516,296+27.2% | Added | History |
| MGNXMacrogenics Inc | COM | 9,953,313 | $95.8M | 1.5% | +150,000+1.5% | Added | History |
| BDXBecton Dickinson & Co | Stock | 388,068 | $94.6M | 1.4% | +83,838+27.6% | Added | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,011,000 | $89.3M | 1.4% | −2,500−0.1% | Reduced | History |
| MDTMedtronic plc | Stock | 970,772 | $80.0M | 1.2% | +329,280+51.3% | Added | History |
| EVHEvolent Health, Inc. | CL A | 2,376,992 | $78.5M | 1.2% | −1,300,123−35.4% | Reduced | History |
| EWEdwards Lifesciences Corp | Stock | 1,018,998 | $77.7M | 1.2% | −6,459−0.6% | Reduced | History |
| EXASExact Sciences Corp | COM | 1,047,786 | $77.5M | 1.2% | −72,033−6.4% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 3,513,351 | $76.1M | 1.2% | 00.0% | Unchanged | History |
| UNHUnitedHealth Group Inc | Stock | 138,152 | $72.7M | 1.1% | −120,053−46.5% | Reduced | History |
| PACBPacific Biosciences of California, Inc. | COM | 7,317,128 | $71.8M | 1.1% | +71,940+1.0% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 2,290,958 | $71.0M | 1.1% | −871,777−27.6% | Reduced | History |
| IMCRImmunocore Holdings plc | ADS | 976,054 | $66.7M | 1.0% | +956,204+4,817.1% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 5,936,082 | $65.4M | 1.0% | +1,051,082+21.5% | Added | History |
| OPCHOption Care Health, Inc. | COM NEW | 1,938,807 | $65.3M | 1.0% | −345,486−15.1% | Reduced | History |
| PODDInsulet Corp | Stock | 289,900 | $62.9M | 1.0% | +25,541+9.7% | Added | History |
| TNDMTandem Diabetes Care Inc | COM NEW | 1,992,317 | $58.9M | 0.9% | −150,452−7.0% | Reduced | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 900,400 | $56.4M | 0.9% | +2,000+0.2% | Added | History |
| ACCDAccolade, Inc. | COM | 4,507,404 | $54.1M | 0.8% | −20,519−0.5% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 94,110 | $52.2M | 0.8% | −20,331−17.8% | Reduced | History |
| EPIXESSA Pharma Inc. | COM NEW | 7,898,583 | $52.1M | 0.8% | 00.0% | Unchanged | History |
| CRLCharles River Laboratories International, Inc. | COM | 217,756 | $51.5M | 0.8% | −11,586−5.1% | Reduced | History |
| PENPenumbra Inc | COM | 203,046 | $51.1M | 0.8% | −34,206−14.4% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 107,788 | $50.8M | 0.8% | −66,099−38.0% | Reduced | History |
| EXELExelixis, Inc. | COM | 2,108,100 | $50.6M | 0.8% | −267,825−11.3% | Reduced | History |
| AXSMAxsome Therapeutics, Inc. | COM | 635,372 | $50.6M | 0.8% | +3,885+0.6% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 821,800 | $49.2M | 0.8% | +27,959+3.5% | Added | History |
| CDNACareDx, Inc. | COM | 3,954,792 | $47.5M | 0.7% | +13,994+0.4% | Added | History |
| BHVNBiohaven Ltd. | COM | 1,075,000 | $46.0M | 0.7% | +1,075,000 | New | History |
| HUMHumana Inc | Stock | 100,472 | $46.0M | 0.7% | −69,574−40.9% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 141,147 | $45.6M | 0.7% | +6,817+5.1% | Added | History |
| INSPInspire Medical Systems, Inc. | COM | 215,600 | $43.9M | 0.7% | +145,232+206.4% | Added | History |
| ALGNAlign Technology Inc | COM | 159,407 | $43.7M | 0.7% | −7,479−4.5% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 535,184 | $41.4M | 0.6% | +522,684+4,181.5% | Added | History |
| HCAHCA Healthcare, Inc. | COM | 152,178 | $41.2M | 0.6% | −3,465−2.2% | Reduced | History |
| TMDXTransMedics Group, Inc. | COM | 518,890 | $41.0M | 0.6% | −17,847−3.3% | Reduced | History |
| SRRKScholar Rock Holding Corp | COM | 2,168,925 | $40.8M | 0.6% | +31,000+1.5% | Added | History |
| VEEVVeeva Systems Inc | Stock | 195,013 | $37.5M | 0.6% | −29,087−13.0% | Reduced | History |
| PRCTPROCEPT BioRobotics Corp | COM | 885,346 | $37.1M | 0.6% | −2,950−0.3% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 281,088 | $34.2M | 0.5% | −3,800−1.3% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 91,476 | $33.1M | 0.5% | −66,962−42.3% | Reduced | History |
| CNCCentene Corp | Stock | 441,853 | $32.8M | 0.5% | −2,190−0.5% | Reduced | History |
| LLYEli Lilly & Co | Stock | 56,212 | $32.8M | 0.5% | −25,329−31.1% | Reduced | History |
| COOCooper Companies, Inc. | COM NEW | 86,037 | $32.6M | 0.5% | −530−0.6% | Reduced | History |
| GMEDGlobus Medical Inc | Stock | 607,772 | $32.4M | 0.5% | −1,843−0.3% | Reduced | History |
| MRKMerck & Co., Inc. | Stock | 290,206 | $31.6M | 0.5% | −1,690−0.6% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 325,776 | $31.4M | 0.5% | −24,112−6.9% | Reduced | History |
| ATRCAtriCure, Inc. | COM | 817,883 | $29.2M | 0.4% | +70,323+9.4% | Added | History |
| CSTLCastle Biosciences Inc | COM | 1,232,378 | $26.6M | 0.4% | +4,347+0.4% | Added | History |
| CICigna Group | Stock | 88,470 | $26.5M | 0.4% | −37,032−29.5% | Reduced | History |
| CORCencora, Inc. | Stock | 126,126 | $25.9M | 0.4% | +109,039+638.1% | Added | History |
| PRVAPrivia Health Group, Inc. | COM | 1,051,696 | $24.2M | 0.4% | −3,482−0.3% | Reduced | History |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 8,535,839 | $24.0M | 0.4% | +400,000+4.9% | Added | History |
| SWAVShockwave Medical, Inc. | COM | 124,810 | $23.8M | 0.4% | −129,469−50.9% | Reduced | History |
| SRPTSarepta Therapeutics, Inc. | COM | 237,286 | $22.9M | 0.4% | −4,466−1.8% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 4,494,458 | $22.7M | 0.3% | 00.0% | Unchanged | History |
| HOLXHologic Inc | COM | 289,864 | $20.7M | 0.3% | −272−0.1% | Reduced | History |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 1,131,111 | $20.4M | 0.3% | −671,852−37.3% | Reduced | History |
| DHRDanaher Corp | Stock | 84,310 | $19.5M | 0.3% | −52,223−38.2% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 694,821 | $18.9M | 0.3% | 00.0% | Unchanged | History |
| TMOThermo Fisher Scientific Inc. | Stock | 35,342 | $18.8M | 0.3% | −31,126−46.8% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 4,851,579 | $18.1M | 0.3% | 00.0% | Unchanged | History |
| SILKSilk Road Medical Inc | COM | 1,435,682 | $17.6M | 0.3% | +5,120+0.4% | Added | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 839,996 | $16.7M | 0.3% | −16,362−1.9% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 293,173 | $16.4M | 0.3% | −1,259−0.4% | Reduced | History |
| NTRANatera, Inc. | COM | 256,584 | $16.1M | 0.2% | −1,102−0.4% | Reduced | History |
| ESPREsperion Therapeutics, Inc. | COM | 4,204,264 | $12.6M | 0.2% | 00.0% | Unchanged | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 201,754 | $12.1M | 0.2% | −76,400−27.5% | Reduced | History |
| AMGNAmgen Inc | Stock | 34,205 | $9.85M | 0.2% | −14,268−29.4% | Reduced | History |
| PHRPhreesia, Inc. | COM | 421,573 | $9.76M | 0.1% | −157,466−27.2% | Reduced | History |
| OMOutset Medical, Inc. | COM | 1,760,134 | $9.52M | 0.1% | −648,296−26.9% | Reduced | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 10,709 | $9.41M | 0.1% | −4,230−28.3% | Reduced | History |
| OMCLOmnicell, Inc. | COM | 223,816 | $8.42M | 0.1% | −15,463−6.5% | Reduced | History |
| DOCSDoximity, Inc. | CL A | 264,035 | $7.40M | 0.1% | −135,422−33.9% | Reduced | History |
| ILMNIllumina, Inc. | COM | 44,993 | $6.26M | 0.1% | −27,037−37.5% | Reduced | History |
| GBIOGeneration Bio Co. | COM | 3,617,080 | $5.97M | 0.1% | 00.0% | Unchanged | History |
| TDOCTeladoc Health, Inc. | COM | 259,404 | $5.59M | 0.1% | −96,245−27.1% | Reduced | History |
| RMDResmed Inc | COM | 30,320 | $5.22M | 0.1% | −46,376−60.5% | Reduced | History |
| ONCBeOne Medicines Ltd. | ADR | 28,600 | $5.21M | 0.1% | −24,600−46.2% | Reduced | History |
| JNJJohnson & Johnson | Stock | 28,280 | $4.43M | 0.1% | +5,457+23.9% | Added | History |
| NVRONevro Corp | COM | 197,324 | $4.25M | 0.1% | −847−0.4% | Reduced | History |
| RDYDr Reddys Laboratories Ltd | ADR | 60,900 | $4.24M | 0.1% | −19,300−24.1% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 51,305 | $4.16M | 0.1% | −56,045−52.2% | Reduced | History |
| MTEMMolecular Templates, Inc. | COM NEW | 1,029,820 | $3.84M | 0.1% | −1,793−0.2% | Reduced | History |
Sold out since Q3 2023 (18)
Positions held at the end of Q3 2023 that are gone from this filing.
| Security | Class | Shares in Q3 2023 | Value in Q3 2023 | % of portfolio in Q3 2023 | History |
|---|---|---|---|---|---|
| JAZZJazz Pharmaceuticals plc | SHS USD | 266,226 | $34.5M | 0.6% | History |
| PNTPOINT Biopharma Global Inc. | COM | 2,351,160 | $15.7M | 0.3% | History |
| AMEDAmedisys Inc | COM | 106,387 | $9.94M | 0.2% | History |
| MRSNMersana Therapeutics, Inc. | COM | 5,218,625 | $6.63M | 0.1% | History |
| SGENSeagen Inc. | COM | 22,000 | $4.67M | 0.1% | History |
| Olink Hldg AB680710100 | SPONSORED ADS | 217,256 | $3.20M | 0.1% | – |
| GHGuardant Health, Inc. | COM | 74,525 | $2.21M | <0.1% | History |
| AKROAkero Therapeutics, Inc. | COM | 25,000 | $1.26M | <0.1% | History |
| VTYXVentyx Biosciences, Inc. | COM | 24,500 | $850.9K | <0.1% | History |
| SEERSeer, Inc. | COM CL A | 123,426 | $272.8K | <0.1% | History |
| DGXQuest Diagnostics Inc | COM | 1,324 | $161.3K | <0.1% | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 38,000 | $109.4K | <0.1% | – |
| EQIXEquinix Inc | COM | 40 | $29.1K | <0.1% | History |
| EVTCEVERTEC, Inc. | COM | 739 | $27.5K | <0.1% | History |
| INFYInfosys Ltd | SPONSORED ADR | 1,130 | $19.6K | <0.1% | History |
| UMCUnited Microelectronics Corp | SPON ADR NEW | 2,698 | $18.9K | <0.1% | History |
| TSMTaiwan Semiconductor Manufacturing Co Ltd | ADR | 1,089 | $1.96K | <0.1% | History |
| ASRSoutheast Airport Group | SPON ADR SER B | 135 | $165 | <0.1% | History |